Congestive Heart Failure for the Primary Care Physician

Article Sidebar

PDF
Published: Oct 31, 2022
DOI: https://doi.org/10.47191/ijmscrs/v2-i10-33
Keywords:
..

Main Article Content

Aranza Vazquez Ruvalcaba
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
Diana Gala Botello Fajardo
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
Oliva Rocha Manzo
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
María Jimena Talamante Madrid
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
Ana Ruth Hernandez Aguirre
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
Renata Monserrat Espejo Nuño
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico
Paulina García de León Flores
School of Medicine, Autonomous University of Guadalajara. Guadalajara, Jalisco, Mexico

Abstract

Congestive heart failure is a clinical condition in which the heart cannot send enough blood to meet the body's metabolic needs due to pathological cardiac changes. In recent decades, a progressive increase in patients affected by this disease has been observed; this could be due to the increase in population age throughout the world, as it is a disease that mainly affects elderly individuals, a higher rate of general healing as a decrease in mortality results in a more significant number of patients affected by it, as well as more effective treatments for cardiac pathologies such as primary angioplasty in acute myocardial infarction, causing a more substantial number of patients with decreased cardiac function.

Article Details

How to Cite
Ruvalcaba, A. V. ., Botello Fajardo, D. G. ., Manzo, O. R. ., Talamante Madrid, M. J., Hernandez Aguirre, A. R. ., Espejo Nuño, R. M., & de León Flores, P. G. . (2022). Congestive Heart Failure for the Primary Care Physician. International Journal of Medical Science and Clinical Research Studies, 2(10), 1186–1194. https://doi.org/10.47191/ijmscrs/v2-i10-33
Issue
Vol. 2 No. 10 (2022): Volume 02 Issue 10 October 2022
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. (2013). ACCF/AHA guideline for managing heart failure: a report of the American College of Cardiology

Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol [Internet]. 2013;62(16):e147-239.

Availablefrom: http://dx.doi.org/10.1016/j.jacc.2013.05.019

II. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: A report from the American Heart Association: A report from the American Heart Association. Circulation [Internet]. 2020;141(9):e139–596. Available from:

http://dx.doi.org/10.1161/CIR.0000000000000757

III. Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med [Internet]. 2008;168(19):2138–45. Available from: http://dx.doi.org/10.1001/archinte.168.19.2138

IV. cdc.gov. [cited 2022 Jul 31]. Available from: https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm

V. Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ Res [Internet]. 2018;122(4):624–38. Available from: http://dx.doi.org/10.1161/CIRCRESAHA.117.311586

VI. Barker JC, Mitteness LS. Shedding light on nocturia. Geriatr Nurs [Internet]. 1989 [cited 2022 Jul 31];10(5):239–40. Available from:

https://www.ncbi.nlm.nih.gov/books/NBK293/

VII. Okoshi MP, Capalbo RV, Romeiro FG, Okoshi K. Cardiac cachexia: Perspectives for prevention and treatment. Arch Bras Cardiol [Internet]. 2016; Available from: http://dx.doi.org/10.5935/abc.20160142

VIII. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine vol 1 20/E (book). 20th ed. McGraw-Hill Education/Medical; 2018.

IX. Colucci WS. Evaluation of the patient with suspected heart failure. Post TW, editor.

X. Givertz MM, Haghighat A. High-output heart failure. Post TW, editor.

XI. Filippatos TD, Elisaf MS. Hyponatremia in patients with heart failure. World J Cardiol [Internet]. 2013;5(9):317–28. Available from:

http://dx.doi.org/10.4330/wjc.v5.i9.317

XII. Rosano GM, Vitale C, Seferovic P. Heart failure in patients with diabetes mellitus. Card Fail Rev [Internet]. 2017;3(1):52–5. Available from:

http://dx.doi.org/10.15420/cfr.2016:20:2

XIII. Hilscher M, Sanchez W. Congestive hepatopathy: Congestive hepatopathy. Clin Liver Dis (Hoboken) [Internet]. 2016;8(3):68–71. Available from: http://dx.doi.org/10.1002/cld.573

XIV. Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: prevalence, characteristics, and prognostic significance: LIVER DYSFUNCTION IN CHRONIC HEART FAILURE. Eur J Clin Invest [Internet]. 2012;42(2):153–63. Available from: http://dx.doi.org/10.1111/j.1365-2362.2011.02573.x

XV. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. (2017). ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation [Internet]. 2017;136(6):e137–61. Available from: http://dx.doi.org/10.1161/CIR.0000000000000509

XVI. Suzuki S, Sugiyama S. The molar ratio of N-terminal pro-B-type natriuretic peptide/B-type natriuretic peptide for heart failure-related events in stable outpatients with cardiovascular risk factors. Intern Med [Internet]. 2018; Available from: http://dx.doi.org/10.2169/internalmedicine.0471-17

XVII. Chen Y, Wen Z, Peng L, Liu X, Luo Y, Wu B, et al. Diagnostic value of MR-proANP for heart failure in patients with acute dyspnea： a meta-analysis. Acta Cardiol [Internet]. 2020;75(1):68–74. Available from: http://dx.doi.org/10.1080/00015385.2018.1550887

XVIII. Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the American Heart Association. Circulation [Internet]. 2017;135(22):e1054–91. Available from:

http://dx.doi.org/10.1161/CIR.0000000000000490

XIX. Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM, et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J [Internet]. 2004;147(3):546–52. Available from: http://dx.doi.org/10.1016/j.ahj.2003.10.014

XX. Wettersten N, Maisel A. Role of cardiac troponin levels in acute heart failure. Card Fail Rev [Internet]. 2015;1(2):102–6. Available from:

http://dx.doi.org/10.15420/cfr.2015.1.2.102

XXI. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. (2016). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the exceptional contribution of the Heart Failure Association (HFA) ) of the ESC. Eur Heart J [Internet]. 2016;37(27):2129–200. Available from:

http://dx.doi.org/10.1093/eurheartj/ehw128

XXII. Salerno M, Sharif B, Arheden H, Kumar A, Axel L, Li D, et al. Recent advances in cardiovascular magnetic resonance: Techniques and Applications: Techniques and applications. Circ Cardiovascular Imaging [Internet]. 2017;10(6). Available from:

http://dx.doi.org/10.1161/CIRCIMAGING.116.003951

XXIII. Omar AMS, Bansal M, Sengupta PP. Advances in echocardiographic imaging in heart failure with reduced and preserved ejection fraction. Circ Res [Internet]. 2016;119(2):357–74. Available from:

http://dx.doi.org/10.1161/CIRCRESAHA.116.309128

XXIV. Natanzon A, Kronzon I. Pericardial and pleural effusions in congestive heart failure-anatomical, pathophysiologic, and clinical considerations. Am J Med Sci [Internet]. 2009;338(3):211–6. Available from:

http://dx.doi.org/10.1097/MAJ.0b013e3181a3936f

XXV. McDowell K, Petrie MC, Raihan NA, Logue J. Effects of intentional weight loss in patients with obesity and heart failure: a systematic review. Obes Rev [Internet]. 2018;19(9):1189–204. Available from:

http://dx.doi.org/10.1111/obr.12707

XXVI. Department of Health and Human Services and US Department of Agriculture. Dietary guidelines for Americans. 2015.

XXVII. Izadi M, Alemzadeh-Ansari MJ, Kazemisaleh D, Moshkani-Farahani M. Air travel considerations for the patients with heart failure. Iran Red Crescent Med J [Internet]. 2014;16(6):e17213. Available from:

http://dx.doi.org/10.5812/ircmj.17213

XXVIII. Travel and heart disease [Internet]. www.heart.org. [cited 2022 Jul 31]. Available from:

https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/travel-and-heart-disease

XXIX. Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G, et al. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet [Internet]. 2020;396(10254):819–29. Available from: http://dx.doi.org/10.1016/S0140-6736(20)31824-9

XXX. von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure: An overview. JACC Heart Fail [Internet]. 2019;7(1):36–46. Available from: http://dx.doi.org/10.1016/j.jchf.2018.07.015

XXXI. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail [Internet]. 2003;9(3):163–9. Available from:

http://dx.doi.org/10.1111/j.1527-5299.2003.01356.x

XXXII. Richards TR, Tobe SW. Combining other antihypertensive drugs with β-blockers in hypertension: a focus on safety and tolerability. Can J Cardiol [Internet]. 2014;30(5 Suppl): S42-6. Available from:

http://dx.doi.org/10.1016/j.cjca.2013.08.012

XXXIII. Allen LA, Fang JC. Goldilocks dilemma of dose titration in heart failure with reduced ejection fraction: Too little, too much, or just right?: Too little, too much or just right? Circ Heart Fail [Internet]. (2017);10(8). Available from:

http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004406

XXXIV. Leyva F, Zegard A, Acquaye E, Gubran C, Taylor R, Foley PWX, et al. Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy. J Am Coll Cardiol [Internet]. 2017;70(10):1216–27. Available from:

http://dx.doi.org/10.1016/j.jacc.2017.07.712

XXXV. Peal JE, Mathews IG, Runnett C, Thomas HE, Ripley DP. An update on cardiac implantable electronic devices for the general physician. JR Coll Physicians Edinb [Internet]. 2018;48(2):141–7. Available from:

http://dx.doi.org/10.4997/JRCPE.2018.208

XXXVI. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons: A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the ACC/AHA /NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. Circulation [Internet]. 2008;117(21):e350-408. Available from:

http://dx.doi.org/10.1161/CIRCUALTIONAHA.108.189742

XXXVII. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. (2013). ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA): The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J [Internet]. 2013;34(29):2281–329. Available from:

http://dx.doi.org/10.1093/eurheartj/eht150

XXXVIII. Mechanical circulatory support in a nutshell [Internet]. American College of Cardiology. [cited 2022 Jul 31]. Available from:

https://www.acc.org/latestincardiology/articles/2015/11/12/09/28/mechanical-circulatory-support-in-a-nutshell

XXXIX. Aronson D. Cardiorenal syndrome in acute decompensated heart failure. Expert Rev Cardiovasc Ther [Internet]. 2012;10(2):177–89. Available from:

http://dx.doi.org/10.1586/erc.11.193

XL. Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American heart association. Circulation [Internet]. 2019;139(16):e840–78. Available from: http://dx.doi.org/10.1161/CIR.0000000000000664

XLI. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol [Internet]. 2002;40(6):1106–13. Available from:

http://dx.doi.org/10.1016/s0735-1097(02)02125-3

XLII. UpToDate. ASAMonitor [Internet]. 2021 [cited 2022 Jul 31];85(10):23–23. Available from:

https://www.uptodate.com/contents/prognosis-of-heart-failure